Fingerprint
Dive into the research topics of 'Effect of Crizanlizumab, a P-Selectin Inhibitor, in COVID-19: A Placebo-Controlled, Randomized Trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Effect of Crizanlizumab, a P-Selectin Inhibitor, in COVID-19: A Placebo-Controlled, Randomized Trial
Thorsten M. Leucker, William O. Osburn, Paula Reventun, Kimberley Smith, Brian Claggett, Bridget Anne Kirwan, Sophie de Brouwer, Marlene S. Williams, Gary Gerstenblith, David N. Hager, Michael B. Streiff, Scott D. Solomon, Charles J. Lowenstein
Research output: Contribution to journal › Article › peer-review